27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Slides:

Advertisements

Similar presentations

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.

1 |1 | Countries using and planning to introduce IPV.

Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

Vaccine in National Immunization Programme Update March 2015.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

1 |1 | Countries using and planning to introduce IPV.

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

World Health Organization

Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.

1 |1 | Countries using and planning to introduce IPV.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.

NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.

Vaccine in National Immunization Programme Update April 2016.

World Health Organization

Data quality for polio eradication: Accuracy & reliability

Perspective and Update

SAGE 2010 Sampling Distribution

Global Polio Eradication: Current Status, Challenges and Future Directions Steven Wassilak, MD Centers for Disease Control and Prevention, Atlanta APHA.

Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.

reporting rate of discarded cases* per 100'000 population**

Ageing Matters Somnath Chatterji Information, Evidence and Research

World Health Organization

PROGRESS IN GLOBAL TB CONTROL

Monthly Distribution of Wild Poliovirus Cases1,

SAGE 2009 Sampling Distribution

06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries Having Introduced Hib Vaccine

Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010

Circulating Vaccine-derived Poliovirus*, last 6 months

Sampling Distribution

15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016

Monthly Distribution of Wild Poliovirus Cases1,

(70 countries or 36%) (23 countries or 12%)

Countries with Genotype data available

Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.

World Health Organization

24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

World Health Organization

Onset of most recent WPV1 Case Number of WPV infected districts

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries having introduced HepB vaccine

No new positives this week

05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Most-affected regions in the Russian Federation

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Mapping Levels of Palliative Care Development: A Global Update

Countries Using Mening Vaccine in National Immunization Schedule 2011

- Use same categories as for bar chart below Introduced Without GAVI

Onset of most recent case Number of infected districts

PROGRESS IN GLOBAL TB CONTROL

04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.

THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION

Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.

16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Circulating Vaccine-derived Poliovirus1,

2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)

World Health Organization

World Health Organization

Presentation transcript:

27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community sampling. The boundaries and names shown and the designations used in the maps in this document do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2017. All rights reserved Data in WHO HQ as of 14 Nov. 2017 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus & cVDPV Cases1, Previous 12 Months2 27/08/2019 Global Wild Poliovirus & cVDPV Cases1, Previous 12 Months2 Wild poliovirus type 1 cVDPV type 2 Endemic country 1Excludes viruses detected from environmental surveillance 2Onset of paralysis 15 November 2016 – 14 November 2017 Data in WHO HQ as of 14 Nov. 2017 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus & cVDPV Cases1, Previous 6 Months2 27/08/2019 Global Wild Poliovirus & cVDPV Cases1, Previous 6 Months2 Wild poliovirus type 1 cVDPV type 2 Endemic country 2Current rolling 6 months: 15 May 2017 – 14 November 2017 3Same period previous year: data reported from 15 May 2016 1Excludes viruses detected from environmental surveillance 2Onset of paralysis 15 May 2017 – 14 November 2017 Data in WHO HQ as of 14 Nov. 2017 Data in WHO HQ as of 30 Nov 2010

Global Wild Poliovirus 2012 - 2017 27/08/2019 Global Wild Poliovirus 2012 - 2017 Data in WHO HQ as of 14 Nov. 2017 Data in WHO HQ as of 30 Nov 2010

Global Circulating Vaccine-derived Poliovirus Cases1,2,3, 2000 - 2017 27/08/2019 Data in WHO/HQ as of 14 Nov. 2017 1For cVDPV definition see http://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf. Niger 2006, Niger 2009, Niger 2010, Chad 2010 cVDPVs are linked to the Nigeria outbreak. Kenya 2012 cVDPVs are linked to the Somalia outbreak. Nigeria figures include cases with WPV1/cVDPV2 mixture: 2005 - 2, 2006 - 1, 2007 - 1, 2008 - 3, 2009 - 1, 2011 - 1; WPV3/cVPDV2 mixture: 2007 - 2. 21 cVDPV2 from a contact of a WPV1 case in Nigeria not included in country and global case count. 3Figures include multiple emergences and transmission chains. Data in WHO HQ as of 30 Nov 2010

Global Surveillance Indicators: Year to Date Comparison 2016 & 2017: 01 January to 14 November 2017* 27/08/2019 *Data for 2016 as of 15 Nov. 2016 and for 2017 as of 14 Nov. 2017 For data at country, regional and global levels from 2000 onwards, see the WHO website at https://extranet.who.int/polis/public/CaseCount.aspx Data in WHO HQ as of 30 Nov 2010